Genetic Markers for Ulcerative Colitis Susceptibility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying susceptibility to ulcerative colitis (UC) are limited, with little known about the genetic architecture of UC compared to Crohn's disease, and existing genome-wide analyses have not systematically investigated UC-specific susceptibility genes.
Innovation Solution
A genome-wide association study (GWAS) using 440,794 SNPs in 1,167 UC cases and 777 healthy controls identified new susceptibility loci, particularly focusing on the IL10 gene and the HLA complex, with replication in multiple panels, to determine genetic markers associated with increased susceptibility to UC.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a genome-wide association study is conducted to identify UC susceptibility genes, then the identification of new susceptibility loci is improved, but the complexity of the analysis and resources required increase
Solution Approach 1:
The genome-wide association study was segmented into multiple independent panels (Panel A with 777 controls/1,167 UC cases, Panel B with 985 controls/523 UC cases, Panel C with 1,091 controls/304 UC cases, and Panel D with 1,015 controls/1,028 UC cases). This segmentation allowed systematic investigation of UC susceptibility across different populations while managing the complexity of genome-wide analysis through modular, replicated studies.
2Reliability
If replication across multiple panels is performed to validate findings, then the reliability of identified markers is improved, but the time and resources required increase
Solution Approach 1:
The study design incorporated preliminary identification of susceptibility loci in Panel A, followed by systematic replication in Panels B, C, and D. This preliminary action approach allowed the research team to identify candidate markers first, then efficiently validate them across multiple independent cohorts, reducing overall research time compared to simultaneous multi-panel analysis.
Solution Approach 2:
The replication panels provided feedback on the validity of susceptibility markers identified in Panel A. The consistent results across Panels B, C, and D confirmed the reliability of markers such as rs3024505 near IL10 and rs12612347 near ARPC2, while allowing refinement of association estimates through meta-analysis.
3Adaptability or versatility
If focus is placed on UC-specific susceptibility genes rather than shared IBD genes, then the specificity of findings for UC is improved, but the ability to leverage existing CD knowledge is reduced
Solution Approach 1:
The study applied local quality by focusing specifically on UC susceptibility while recognizing the differential genetic architecture between UC and CD. The results showed that while some loci are shared (such as IL23R and IL12B), UC has distinct susceptibility genes including IL10 and ARPC2, allowing tailored therapeutic approaches for each subtype.
Data Source
AI summary
A method is provided for detecting an increased susceptibility to ulcerative colitis by determining the presence of a polymorphism at position 256 of the nucleotide sequence of rs3024505 in which C is substituted by T or the presence of a polymorphism at position 501 of the nucleotide sequence of rs12612347 in which G is substituted by A.